der Thread wurde von cannabistrader am 27.03 eröffnet,...
hättest DU (
http://www.ariva.de/forum/auscann-on-fire-546604?page=0#jumppos3 ) dich selbst mal bischen ins Zeug gelegt und im www recherchiert,...hättest DU den Thread eröffnet.
Vielleicht meldest DU dich einfach auf dem BLog von cannabistrader an und informierst dich frühzeitig(er)..... bislang war es DIR jedenfalls nicht möglich (gem. deinem User-Profil) nur eine einzige Diskussion anszustossen.....
Hätte der Thread-Eröffner eine Empfehlung gegeben,.... wärst DU vermutlich der Erste der sich über die aktuelle Performance seit Thread-Eröffnung beschert! (rein subjektiv - überzeug uns! )
Aber immer nur schön nehmen und nie geben... Top!
Wie ich das liebe!
**************************************************
http://www.asx.com.au/asx/statistics/...amp;timeframe=D&period=M6 TWH changed to AC8
CRW changed to TWH
CKR changed to CRW
ALI changed to CKR
RVI changed to ALI
Zitat:"§AusCann Group Holdings Ltd (ASX:AC8 or ‘the Company’)
is pleased to announce it has signed a Heads of Agreement to form an exclusive
strategic partnership with Tasmanian Alkaloids Pty Ltd. Tasmanian Alkaloids
, owned by the global private investment firm SK Capital Partners,is one of the world’s
largest manufacturers of controlled substances,producing alkaloid raw material
grown in Tasmania. Tasmanian Alkaloidsis an established manufacturer of alkaloid
raw materials. Operating since 1976, today Tasmanian produces approximately 40% of the world’s alkaloid raw material crop in Tasmania. It boasts a modern manufacturing facilit
y, which is fully compliant with Good Manufacturing Practice standards.
Tasmanian Alkaloids has established relationships with many of the world’s leading
pharmaceutical companies and is the largest producer and exporter of thebaine,
and also produces oripavine and codeine at its Tasmanian facility.
AusCann and Tasmanian Alkaloids will work together to establish cultivation, manufacturing
and distribution operations for medicinal cannabis in Australia and overseas.
Through the strategic partnership, AusCann will have access to Tasmanian Alkaloids’
wealth of expertise. Jointly, the two companies will secure a licence to cultivate and manufacture
medicinal cannabis in Tasmania. The Tasmanian license will be in addition to AusCann’s current medical cannabis cultivation licence granted last week by the Office of Drug Control .
AusCann will continue to import product from its partner Canopy Growth Corporation
, North America’s largest producer of medicinal cannabis, ahead of the parties being able to supply Australian medicines. " ENDE Zitat
Source:
http://www.asx.com.au/asxpdf/20170517/pdf/43j9v8z1zltfbt.pdfhttp://www.asx.com.au/asx/statistics/...amp;timeframe=D&period=M6